Updated Jul 16, 2026
Duncan Gregory Scott is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Gregory Scott Duncan is the Chief Executive Officer and a Director at Dogwood Therapeutics, Inc., a biotechnology company focused on antiviral therapies. He has also been involved with CorMedix Inc., contributing to the development of treatments for various medical conditions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-28 | CRMD | CorMedix Inc. | A — Grant or award | 30.5K | $0.00 | |
| 2025-09-16 | CRMD | CorMedix Inc. | M — Option exercise | 13.3K | $8.32 | $111K |
Gregory Scott Duncan is the Chief Executive Officer and a Director at Dogwood Therapeutics, Inc., a biotechnology company focused on antiviral therapies. He has also been involved with CorMedix Inc., contributing to the development of treatments for various medical conditions.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Duncan Gregory Scott profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.